Q2 2025 Earnings Call Transcript July 29, 2025 Merck & Co., Inc. beats earnings expectations. Reported EPS is $2.13, ...

India], July 28: Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks ‘World ART (Assisted Reproductive ...

MSFT, BABA, and MRK headline today's top analyst picks, with AI, global e-commerce, and oncology driving mixed growth stories ...

In a shakeup for the sprawling 102-acre campus in Kenilworth, CoreWeave has purchased a data center site at NEST for $322 ...

MSFT, BABA, and MRK lead today's top analyst picks, with AI, e-commerce, and cancer drug strategies in sharp focus.

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

However, Merck & Co., Inc. (NYSE:MRK)’s shares have lost 16% year-to-date, primarily on the back of weak earnings reports and worries about the firm’s GARDASIL drug.

Designed by Sylvia Richards, the mass-timber addition to Adimab's Lebanon campus is sensitive to the lushly forested wetland ...

Also in today’s newsletter, EU warns Europe’s roads unfit for war, UBS currency derivatives and Botswana’s push on De Beers ...

Merck is a massive company with strong fundamentals and underlying value at a heavily discounted price. Click here to find out why I rate MRK a Buy.

Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent.

ColorComm hosted its tenth annual conference with speakers and attendees "breaking new ground" to mark change in the industry.